Anula Jayasuriya Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

Anula Jayasuriya is of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 10,000 shares of LCTX, which is worth approximately $9,200. The most recent transaction as insider was on Dec 29, 2023, when has been sold 10,000 shares (Common Shares, no par value) at a price of $1.09 per share, resulting in proceeds of $10,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K

0% 3M change

n/a 12M change

Total Value Held $9,200

Anula Jayasuriya Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 29 2023	BUY Open market or private purchase	$10,900 $1.09 p/Share	10,000 Added 50.0%	10,000 Common Shares, no par ...

Also insider at

JAGX

Jaguar Health, Inc. Healthcare

Director